ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 12.6d
Immunosuppression Use: Antirejection Treatment from Transplant
to One Year Post Transplant, 1991 to 2000
Recipients with Lung Transplants

  Year of Transplant
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Transplants 406 535 674 738 893 832 946 891 918 971
Tx with Antirejection Treatments 206 257 379 388 475 372 417 400 385 414
Antibodies Category Usage 12.6% 8.6% 14.0% 17.8% 9.5% 11.0% 11.5% 14.8% 16.4% 18.8%
ALG 0.0% 0.0% 0.3% 1.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ATG 0.0% 0.8% 5.0% 10.3% 5.7% 7.3% 6.5% 10.0% 7.3% 7.0%
NRATG/NRATS 0.0% 0.0% 0.0% 0.3% 0.0% 0.3% 1.4% 0.8% 0.8% 0.2%
OKT3 12.6% 7.8% 9.5% 7.7% 4.2% 3.8% 4.3% 3.3% 3.1% 2.7%
Thymoglobulin 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.8% 5.2% 6.0%
Zenapax 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 1.0% 2.7%
Simulect 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.8% 2.9%
Corticosteroids Category Usage 95.6% 96.9% 91.0% 92.5% 93.7% 90.1% 93.8% 91.8% 92.7% 87.7%
Prednisone 20.4% 19.1% 14.5% 15.2% 18.9% 15.3% 13.4% 17.3% 17.4% 15.7%
Methylprednisolone 90.3% 90.7% 81.5% 84.0% 84.8% 84.9% 88.2% 84.8% 84.9% 82.1%

Source: OPTN/SRTR Data as of August 1, 2002.
Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.